Combined levamisole with recombinant interleukin-2 (IL-2) in patients with advanced renal cell carcinoma: a phase II study. [electronic resource]
Producer: 19980414Description: 139-41 p. digitalISSN:- 0277-3732
- Adjuvants, Immunologic -- administration & dosage
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Carcinoma, Renal Cell -- drug therapy
- Drug Therapy, Combination
- Female
- Humans
- Interleukin-2 -- administration & dosage
- Kidney Neoplasms -- drug therapy
- Levamisole -- administration & dosage
- Male
- Middle Aged
- Recombinant Proteins -- administration & dosage
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.